Track topics on Twitter Track topics that are important to you
LONDON, UK & MONTREAL, QC — DalCor Pharmaceuticals reports it is ahead of its enrollment schedule with the randomization of over 1,000 of the planned 5,000 patients that will take part in the company’s Phase 3 “dal-GenE” clinical trial. “We are pleased and gratified that recruitment goals are ahead of schedule,” said Dr. Jean-Claude Tardif, director [&hellipNEXT ARTICLE
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...